Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on November 4, 2026

Nov. 4, 2026

Kamau Therapeutics Announces First Multi-Patient Clinical Data Showing Precise Correction of the Sickle Cell Mutation and Restoration of Adult Hemoglobin

Indeterminate GlobeNewswire

Nov. 4, 2026

Atavistik Bio to Highlight Momentum Across Hematology Pipeline with Harmony-HHT Clinical Trial Update and New Preclinical Data from HHT and JAK2 V617F Programs at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Climb Bio to Present New Data for Budoprutug in Immune Thrombocytopenia at the 68th American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire

Nov. 4, 2026

Damora Therapeutics to Present New Preclinical Data Highlighting Potentially Best-in-Class Pan-Mutant Activity of DMR-001 in Mutant Calreticulin (mutCALR)-driven Myeloproliferative Neoplasms (MPN) at the American Society of Hematology (ASH) 2026 Annual…

Indeterminate GlobeNewswire

Nov. 4, 2026

Cellectar Biosciences to Present Three Posters Highlighting Durable Clinical Activity of Iopofosine I 131 in Waldenström Macroglobulinemia at the American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire

Nov. 4, 2026

Syndax Highlights Acceptance of 19 Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Abstracts, Including 7 for Oral Presentation, at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Peer-Reviewed Scientific Journal Publishes U.S. Clinical Study Reporting Interim Results of 87.7% Accuracy for IR-MED’s PressureSafe™ Technology in Pressure-Injury Assessment

Indeterminate GlobeNewswire

Nov. 4, 2026

TOMI Environmental Solutions, Inc. Announces Recurring Consumable Agreement with Global Eye Health Company

Indeterminate GlobeNewswire

Nov. 4, 2026

OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models

Indeterminate GlobeNewswire

Nov. 4, 2026

Eliminating Static Without Electricity - MEC Industries Introduces the Powerless ECO Ionizer

Indeterminate GlobeNewswire

Nov. 4, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

AltruBio to Host Virtual R&D Day on ALTB-268 and Ulcerative Colitis on November 11, 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights

Indeterminate GlobeNewswire

Nov. 4, 2026

Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12

Indeterminate GlobeNewswire

Nov. 4, 2026

Aprea Therapeutics Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing

Indeterminate GlobeNewswire

Nov. 4, 2026

Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015

Indeterminate GlobeNewswire

Nov. 4, 2026

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Indeterminate GlobeNewswire